World's Best Scientists 2026 revealed!
Robert Rottapel

Robert Rottapel

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
13338
World Ranking
8813
National Ranking
305

Overview

Robert Rottapel is affiliated with the University of Toronto in Canada and has contributed extensively to research in biochemistry, genetics, molecular biology, and medicine. Their work emphasizes areas such as molecular biology, oncology, immunology, cell biology, and genetics, reflecting a multidisciplinary approach to biomedical science.

The scientist has focused on various research topics, including:

  • PARP inhibition in cancer therapy
  • Hippo pathway signaling and YAP/TAZ
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Clinical Research Studies
  • Ubiquitin and proteasome pathways
  • Axon Guidance and Neuronal Signaling
  • Cancer-related gene regulation

Rottapel's publication record includes numerous papers in prominent journals. Some recent notable publications are:

  • "N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer," 2021, Gastroenterology
  • "Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice," 2021, Nature Genetics
  • "Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology," 2021, Cancer Immunology Immunotherapy
  • "Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort," 2020, Autoimmunity Reviews
  • "Advances in ovarian cancer, from biology to treatment," 2021, Nature Cancer

The scientist has published frequently in several key venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Gastroenterology
  • Nature Genetics
  • Journal of Clinical Investigation

Collaborations appear across multiple coauthors with whom Rottapel has published extensively. Frequent coauthors include:

  • Yoshinori Matsumoto
  • José La Rose
  • Yosuke Asano
  • Jun Wada
  • Amit M. Oza

These collaborations and publication venues reflect a broad network and engagement with various institutions and research groups focused on understanding molecular mechanisms underlying cancer, immune regulation, and cellular signaling pathways.

Best Publications

  • Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA

    Akihide Ryo;Futoshi Suizu;Yasuhiro Yoshida;Kilian Perrem

  • Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling

    Françoise Pagès;Marguerite Ragueneau;Robert Rottapel;Robert Rottapel;Alemseged Truneh

  • The MAGUK family protein CARD11 is essential for lymphocyte activation.

    Hiromitsu Hara;Teiji Wada;Teiji Wada;Chris Bakal;Ivona Kozieradzki;Ivona Kozieradzki

  • Measuring error rates in genomic perturbation screens: gold standards for human functional genomics

    Traver Hart;Kevin R Brown;Fabrice Sircoulomb;Robert Rottapel;Robert Rottapel;Robert Rottapel

  • W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor

    A D Reith;R Rottapel;E Giddens;C Brady

  • Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells

    Richard Marcotte;Kevin R. Brown;Fernando Suarez;Azin Sayad

  • The c-kit receptor ligand functions as a mast cell chemoattractant.

    Cynthia J. Meininger;Hiroshi Yano;Robert Rottapel;Alan Bernstein

  • The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.

    R Rottapel;M Reedijk;D E Williams;S D Lyman

  • A point mutation in CD28 distinguishes proliferative signals from survival signals.

    Klaus Okkenhaug;Klaus Okkenhaug;Linda Wu;Kristine M. Garza;Jose La Rose

  • SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

    Maya Kozlowski;Louise Larose;Fai Lee;Duc Mingh Le

  • Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease

    Sebastian Guettler;Sebastian Guettler;Jose LaRose;Evangelia Petsalaki;Evangelia Petsalaki;Gerald Gish

  • Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation

    Paulo De Sepulveda;Klaus Okkenhaug;Klaus Okkenhaug;Jose La Rose;Robert G. Hawley

  • Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation.

    Paulo De Sepulveda;Subburaj Ilangumaran;Robert Rottapel;Robert Rottapel

  • The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.

    Galland F;Karamysheva A;Pebusque Mj;Borg Jp

  • Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins

    Ioannis D. Dimitriou;Liliana Clemenza;Liliana Clemenza;Andrew J. Scotter;Grace Chen;Grace Chen

  • Autoinhibition of the Kit Receptor Tyrosine Kinase by the Cytosolic Juxtamembrane Region

    Perry M. Chan;Subburaj Ilangumaran;Jose La Rose;Avijit Chakrabartty

  • Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism

    Noam Levaot;Oleksandr Voytyuk;Ioannis Dimitriou;Fabrice Sircoulomb

  • CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly

    Russell G. Jones;Alisha R. Elford;Michael J. Parsons;Linda Wu

  • The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.

    Paul A. Spagnuolo;Jiayi Hu;Rose Hurren;Xiaoming Wang

  • Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence

    Rizwan Haq;James D Brenton;Mark Takahashi;Dina Finan

Frequent Co-Authors

Mitsuhiko Ikura
Mitsuhiko Ikura Princess Margaret Cancer Centre
Klaus Okkenhaug
Klaus Okkenhaug University of Cambridge
Anne-Claude Gingras
Anne-Claude Gingras Lunenfeld-Tanenbaum Research Institute
Benjamin G. Neel
Benjamin G. Neel New York University Langone Medical Center
Pamela S. Ohashi
Pamela S. Ohashi Princess Margaret Cancer Centre
Christopher J. Paige
Christopher J. Paige Princess Margaret Cancer Centre
Jason Moffat
Jason Moffat University of Toronto
Josef M. Penninger
Josef M. Penninger University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Robert Rottapel

Trending Scientists